However, recent reports about the association of B-RAF and/or N-RAS mutations with the prognosis of melanoma patients revealed contradictory results [5], [7], [8], [9], [10], requiring clarification by further studies, particularly given the varying frequencies of the reported B-RAF and N-RAS mutations. The gene discussed is NRAS; the disease is melanoma.